You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 114 No. 10, October 1978 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Corticosteroids in the Treatment of Alopecia Totalis

Systemic Effects

Walter P. Unger, MD, FRCP(C); Robert J. Schemmer, MD

Arch Dermatol. 1978;114(10):1486-1490.


Abstract

• Fifteen patients with alopecia totalis (AT) or alopecia universalis (AU) were treated with combined topical, intralesional, and oral corticosteroids.

All or virtually all scalp hair has regrown on seven patients, and they have been able to discontinue oral corticosteroids without recurrence of AT or AU for periods of three months to 71/2 years, with an average remission of 32 months. Two additional patients are currently receiving 5 mg of prednisone every two days.

Using topical and intralesional corticosteroids in more resistant areas allowed for more rapid lowering of oral doses and thus side effects were minimized.

In view of the usually nearly hopeless prognosis for AT and AU and the results reported here, a trial course of topical, intralesional, and oral corticosteroid treatment would seem to be reasonable for highly motivated patients.

(Arch Dermatol 114:1486-1490, 1978)



Author Affiliations

From the Departments of Dermatology, Wellesley Hospital, Toronto (Dr Unger), the Toronto General Hospital (Dr Schemmer), and the University of Toronto (Drs Unger and Schemmer).


Footnotes

Accepted for publication May 23, 1978.

Reprint requests to 2156 Yonge St, Toronto, Ontario M4S 2A7, Canada (Dr Unger).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Systemic Steroids With or Without 2% Topical Minoxidil in the Treatment of Alopecia Areata
Olsen et al.
Arch Dermatol 1992;128:1467-1473.
ABSTRACT  

Alopecia Areata: A Review of Therapy, Efficacy, Safety, and Mechanism
Fiedler
Arch Dermatol 1992;128:1519-1529.
ABSTRACT  

PUVA Treatment of Alopecia Areata
Claudy and Gagnaire
Arch Dermatol 1983;119:975-978.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1978 American Medical Association. All Rights Reserved.